Department of Defense
Antibodies eye Pacific Island “fever”
May. 14, 2020—Vanderbilt Vaccine Center team isolates monoclonal antibodies against the mosquito-borne Ross River virus, which causes rash, fever and debilitating muscle and joint pain lasting three to six months.
Webinar on engaging with federal government for early career researchers is April 15
Apr. 7, 2019—An April 15 webinar designed for early career investigators will highlight opportunities at key agencies such as the National Institutes of Health, National Science Foundation and Department of Defense. The event will be from noon to 1 p.m. in the Baker Building, Room 800C.
‘Getting funding from the DOD’ topic of workshop Oct. 22
Oct. 15, 2018—Researchers with little to no experience with Department of Defense funding are invited to learn more at an Oct. 22 workshop sponsored by the Office of the Vice Provost for Research.
New target to stop Ebola
May. 21, 2018—A new Vanderbilt study suggests it may be possible to develop antibody therapies or a universal vaccine effective against multiple Ebola virus family members.
Study seeks new ways to detect sensory issues in TBI patients
Oct. 26, 2017—Vanderbilt researcher Tonia Rex, Ph.D., is accustomed to performing studies in her lab with a goal of translating the findings into better diagnoses and treatment tools for the visually impaired.
Harris honored for support of employees’ military service
Jul. 27, 2017—Kaye Harris, MSN, R.N., manager of Supplemental Staffing Programs, has received a Patriotic Employer Award from the Employer Support of the Guard and Reserve (ESGR), a program of the Department of Defense.
Genetics of lung cancer survival
Jun. 29, 2017—Vanderbilt investigators have conducted a first-of-its-kind genome-wide association study of lung cancer survival in African-Americans.
Blood type link to cancer survival
May. 17, 2017—Blood type A was associated with longer ovarian cancer survival in a recent Vanderbilt-led study.
Studies aim to speed, track peripheral nerve recovery
Oct. 6, 2016—Surgeons have limited tools to successfully repair and track the recovery of peripheral nerves that have been severely damaged as a result of a traumatic injury, but Vanderbilt investigators hope to change this through research studies recently funded with more than $3 million in grants from the Department of Defense and the National Institutes of Health.
New breast cancer driver
Aug. 26, 2016—Vanderbilt investigators have demonstrated that a certain protein complex drives tumor progression in aggressive breast cancers.
Breast cancer: finding the smoking gun
Jul. 20, 2016—A new method developed at Vanderbilt may help “inventory” all tumor-promoting genes.
Drug combos enhance ovarian cancer cell death
Aug. 11, 2015—Drugs that target DNA damage improve ovarian cancer cell response to platinum chemotherapies, suggesting new therapeutic opportunities.